Company
Medpace Holdings, Inc. (MEDP)
Standardized SEC financial data for Medpace Holdings, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001668397 · NASDAQ · Services-Commercial Physical & Biological Research.
Operating margin
21.1%
Net margin
17.8%
Revenue growth (YoY)
20.0%
Return on equity
98.3%
Free cash flow
$681.9M
Debt / equity
0.00×
Current ratio
0.74×
EPS (diluted)
$15.28
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $925.9M | $1.14B | $1.46B | $1.89B | $2.11B | $2.53B |
| SG&A expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $277.8M | $461.3M | $28.3M | $245.4M | $669.4M | $497.0M |
| Accounts receivable |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | $258.7M | $263.3M | $388.1M | $433.4M | $608.8M | $713.2M |
| Capital expenditures |
Get MEDP data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/MEDP/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/MEDP/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"